Stocks
Humacyte, Inc.HUMA
NASDAQHealthcareBiotechnology$1.16+1.75%
Develops bioengineered human tissues designed to replace or repair damaged blood vessels, with a focus on acellular tissue engineered vessels used in vascular surgery, dialysis access, and trauma care. The company is a clinical‑stage regenerative medicine developer whose lead products are undergoing...
Market Cap: $165.7M52W Range: $0.88 – $3.36
Congressional Interest in Humacyte, Inc. (HUMA)
1 member of Congress has disclosed 9 trades in Humacyte, Inc. (HUMA), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 4 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
9
Unique Politicians
1
Buys
5
Sells
4
Who in Congress Is Trading HUMA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-05-03 | Thomas H Tuberville | sell | $1K – $15K |
| 2024-05-03 | Thomas H Tuberville | sell | $15K – $50K |